Neal S Parikh1, Babak B Navi2, Sonal Kumar3, Hooman Kamel2. 1. Department of Neurology, Weill Cornell Medical College, New York, New York. Electronic address: nsp2001@nyp.org. 2. Department of Neurology, Weill Cornell Medical College, New York, New York; Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York. 3. Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, New York.
Abstract
BACKGROUND: Liver disease is common and associated with clinical and laboratory evidence of coagulopathy. The association between liver disease and intracranial hemorrhage (ICH) remains unclear. Our aim was to assess whether liver disease increases the risk of ICH. METHODS: We performed a retrospective cohort study based on administrative claims data from California, Florida, and New York acute care hospitals from 2005 through 2011. Of a random 5% sample, we included patients discharged from the emergency department or hospital after a diagnosis of liver disease and compared them to patients without liver disease. Patients with cirrhotic liver disease were additionally analyzed separately. Kaplan-Meier survival statistics were used to calculate cumulative rates of incident ICH, and Cox proportional hazard analysis was used to adjust for demographic characteristics, vascular disease, and Elixhauser comorbidities. Multiple models tested the robustness of our results. RESULTS: Among 1,909,816 patients with a mean follow-up period of 4.1 (±1.8) years, the cumulative rate of ICH after a diagnosis of liver disease was 1.70% (95% confidence interval [CI], 1.55%-1.87%) compared to .40% (95% CI, .39%-.41%) in patients without liver disease (P <.001 by the log-rank test). Liver disease remained associated with an increased hazard of ICH after adjustment for demographic characteristics and vascular risk factors (hazard ratio [HR], 1.8; 95% CI, 1.6-2.0). This was attenuated in models additionally adjusted for general comorbidities (HR, 1.3; 95% CI, 1.2-1.5). CONCLUSIONS: There is a modest, independent association between liver disease and the risk of ICH.
BACKGROUND:Liver disease is common and associated with clinical and laboratory evidence of coagulopathy. The association between liver disease and intracranial hemorrhage (ICH) remains unclear. Our aim was to assess whether liver disease increases the risk of ICH. METHODS: We performed a retrospective cohort study based on administrative claims data from California, Florida, and New York acute care hospitals from 2005 through 2011. Of a random 5% sample, we included patients discharged from the emergency department or hospital after a diagnosis of liver disease and compared them to patients without liver disease. Patients with cirrhotic liver disease were additionally analyzed separately. Kaplan-Meier survival statistics were used to calculate cumulative rates of incident ICH, and Cox proportional hazard analysis was used to adjust for demographic characteristics, vascular disease, and Elixhauser comorbidities. Multiple models tested the robustness of our results. RESULTS: Among 1,909,816 patients with a mean follow-up period of 4.1 (±1.8) years, the cumulative rate of ICH after a diagnosis of liver disease was 1.70% (95% confidence interval [CI], 1.55%-1.87%) compared to .40% (95% CI, .39%-.41%) in patients without liver disease (P <.001 by the log-rank test). Liver disease remained associated with an increased hazard of ICH after adjustment for demographic characteristics and vascular risk factors (hazard ratio [HR], 1.8; 95% CI, 1.6-2.0). This was attenuated in models additionally adjusted for general comorbidities (HR, 1.3; 95% CI, 1.2-1.5). CONCLUSIONS: There is a modest, independent association between liver disease and the risk of ICH.
Authors: Hude Quan; Bing Li; L Duncan Saunders; Gerry A Parsons; Carolyn I Nilsson; Arif Alibhai; William A Ghali Journal: Health Serv Res Date: 2008-08 Impact factor: 3.402
Authors: Mats Ogren; David Bergqvist; Martin Björck; Stefan Acosta; Henry Eriksson; Nils H Sternby Journal: World J Gastroenterol Date: 2006-04-07 Impact factor: 5.742
Authors: Valery L Feigin; Carlene M M Lawes; Derrick A Bennett; Suzanne L Barker-Collo; Varsha Parag Journal: Lancet Neurol Date: 2009-02-21 Impact factor: 44.182
Authors: Henning Grønbaek; Søren P Johnsen; Peter Jepsen; Mette Gislum; Hendrik Vilstrup; Ulrik Tage-Jensen; Henrik T Sørensen Journal: BMC Gastroenterol Date: 2008-05-24 Impact factor: 3.067